1. Search Result
Search Result
Results for "

OTUB1

" in MedChemExpress (MCE) Product Catalog:

19

Inhibitors & Agonists

1

Recombinant Proteins

2

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-151563
    OTUB1/USP8-IN-1
    2 Publications Verification

    Deubiquitinase Cancer
    OTUB1/USP8-IN-1 is a potent dual OTUB1/USP8 inhibitor with IC50 values of 0.17 and 0.28 nM for OTUB1 and USP8, respectively. OTUB1/USP8-IN-1 can be used in research of cancer [1].
    OTUB1/USP8-IN-1
  • HY-143345

    Deubiquitinase Cancer
    EN523 is a OTUB1 recruiter. EN523 targets a non-catalytic allosteric cysteine C23 in the K48-ubiquitin-specific deubiquitinase OTUB1 [1].
    EN523
  • HY-151563A
    OTUB1/USP8-IN-1 TFA
    2 Publications Verification

    Deubiquitinase Cancer
    OTUB1/USP8-IN-1 TFA is the TFA salt form of OTUB1/USP8-IN-1 (HY-151563). OTUB1/USP8-IN-1 TFA is a dual inhibitor for OTUB1/USP8, IC50 for OTUB1 and USP8 is 0.17 and 0.28 nM, respectively. OTUB1/USP8-IN-1 TFA inhibits proliferation of NSCLC cells. OTUB1/USP8-IN-1 TFA exhibits good pharmacokinetic characters in ICR mouse, and exhibits antitumor activity in H1975 xenograft mouse model [1].
    OTUB1/USP8-IN-1 TFA
  • HY-115878

    CFTR Others
    NJH-2-057 is an EN523 OTUB1 recruiter linked to lumacaftor, a agent used to treat cystic fibrosis that binds ΔF508-CFTR.
    NJH-2-057
  • HY-143344

    PROTACs CFTR Inflammation/Immunology
    NJH-2-056 is a deubiquitinase-targeting chimera (DUBTAC) linking the OTUB1 recruiter EN523 to the CFTR chaperone lumacaftor. NJH-2-056 can be used for cystic fibrosis research [1].
    NJH-2-056
  • HY-144999

    Wee1 Cancer
    LEB-03-146 is a WEE1 DUBTAC (deubiquitinase-targeting chimera) linking AZD1775 (Adavosertib) to the OTUB1 recruiter EN523 through a PEG2 linker. LEB-03-146 shows significant WEE1 stabilization in HEP3B hepatoma cancer cells [1].
    LEB-03-146
  • HY-162966

    Cyclic GMP-AMP Synthase PROTACs STING Cancer
    MS7829 is a deubiquitinase-targeting chimera (DUBTAC) that targets cGAS. MS7829 recruits OTUB1 to cGAS, binds covalently to OTUB1, stabilizes the protein abundance of cGAS, and activates the cGAS-STING-IRF3 innate immune signaling pathway in an OTUB1-dependent manner. MS7829 is applicable to cancer-related research [1].
    MS7829
  • HY-RS23172

    Small Interfering RNA (siRNA) Others

    Otub1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Otub1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Otub1 Rat Pre-designed siRNA Set A
    Otub1 Rat Pre-designed siRNA Set A
  • HY-RS09869

    Small Interfering RNA (siRNA) Others

    OTUB1 Human Pre-designed siRNA Set A contains three designed siRNAs for OTUB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    OTUB1 Human Pre-designed siRNA Set A
    OTUB1 Human Pre-designed siRNA Set A
  • HY-RS16735

    Small Interfering RNA (siRNA) Others

    Otub1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Otub1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Otub1 Mouse Pre-designed siRNA Set A
    Otub1 Mouse Pre-designed siRNA Set A
  • HY-143342

    Wee1 Cancer
    LEB-03-144 is a WEE1 DUBTAC (deubiquitinase-targeting chimera) linking AZD1775 (Adavosertib) to the OTUB1 recruiter EN523 through a C3 alkyl linker. LEB-03-144 shows significant WEE1 stabilization in HEP3B hepatoma cancer cells [1].
    LEB-03-144
  • HY-143343

    Wee1 Cancer
    LEB-03-153 is a WEE1 DUBTAC (deubiquitinase-targeting chimera) linking AZD1775 (Adavosertib) to the OTUB1 recruiter EN523 through no linker [1].
    LEB-03-153
  • HY-143340

    Wee1 Cancer
    LEB-03-145 is a WEE1 DUBTAC (deubiquitinase-targeting chimera) linking AZD1775 (Adavosertib) to the OTUB1 recruiter EN523 through a C5 alkyl linker [1].
    LEB-03-145
  • HY-183724

    Deubiquitinase Inflammation/Immunology
    MS8572 is a selective OTUB1 covalent ligand. MS8572 covalently modifies the noncatalytic cysteine 23 residue of OTUB1 and does not inhibit OTUB1 deubiquitinase activity. MS8572 can be used for development of deubiquitinase-targeting chimeras for targeted protein stabilization [1].
    MS8572
  • HY-183725

    DUBTACs Deubiquitinase CFTR Inflammation/Immunology
    MS5128 is an OTUB1-based deubiquitinase-targeting chimera (DUBTAC) targeting CFTR. MS5128 recruits OTUB1 to CFTR to induce deubiquitination and stabilization of CFTR. MS5128 can be used for the research of cystic fibrosis [1]. (Blue: CFTR Ligand (HY-183724); Pink: OTUB1 Ligand (HY-13262); Black: Linker)
    MS5128
  • HY-185122

    CFTR Deubiquitinase Cancer
    MS6178 is a MS5105-based CFTR deubiquitinase-targeted chimera (DUBTAC) that recruits OTUB1 to stabilize ΔF508-CFTR mutant protein in a concentration- and time-dependent manner, with an OTUB1-dependent effect and no impact on CFTR mRNA level. MS6178 can be used for the research of cancer [1].
    MS6178
  • HY-182350

    DUBTACs Deubiquitinase Metabolic Disease
    FXR DUBTAC IN-1 (compound D11) is a deubiquitinase-targeting chimeric molecule (DUBTAC) that targets FXR, with a Ka value of 2.12e-5 M for FXR. FXR DUBTAC IN-1 recruits the deubiquitinase OTUB1, binds to OTUB1 and forms a ternary complex with FXR, reduces the polyubiquitination level of FXR, prevents FXR degradation via the ubiquitin-proteasome pathway, and elevates the protein level of FXR. FXR DUBTAC IN-1 can be used in the research of cholestatic liver injury [1].
    FXR DUBTAC IN-1
  • HY-175934

    Deubiquitinase Cancer
    MS5105 is a covalent ligand of the deubiquitinating enzyme OTUB1, which can be used to construct DUBTACs, such as MS8588 (HY-162967) [1].
    MS5105
  • HY-162967

    PROTACs Cyclic GMP-AMP Synthase STING Inflammation/Immunology Cancer
    MS8588 is a deubiquitinase-targeting chimera (DUBTAC) against cGAS. MS8588 induces targeted stabilization of cGAS, thereby activating downstream signaling pathways. MS8588 activates the cGAS/STING/IRF3 innate immune signaling pathway. MS8588 exhibits antitumor activity [1].
    MS8588

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: